Summit Therapeutics Inc.
SMMTDrugs in Pipeline
7
Phase 3 Programs
5
Upcoming Catalysts
3
Next Catalyst
This month
Market Overview
Stock performance and key metrics
4 upcoming, 0 past
Acquisition — AstraZeneca ($2B)
AstraZeneca is investing $2 billion into Summit Therapeutics to establish a cancer-focused partnership/acquisition tie-up.
3 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
AK112 Injection
Non-Squamous Non-small Cell Lung Cancer
Ridinilazole
Clostridioides Difficile Infection
Drug: Ivonescimab Injection
Metastatic Colorectal Cancer (CRC)
Pembrolizumab Injection
Non-Small Cell Lung Cancer
Ivonescimab Injection
Non-Small Cell Lung Cancer
Fidaxomicin
Clostridium Difficile Infection
SMT19969
Clostridium Difficile Infection
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
AK112 Injection | Phase 3 | Non-Squamous Non-small Cell Lung Cancer | - | - |
Ridinilazole | Phase 3 | Clostridioides Difficile Infection | - | - |
Drug: Ivonescimab Injection | Phase 3 | Metastatic Colorectal Cancer (CRC) | - | - |
Pembrolizumab Injection | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Ivonescimab Injection | Phase 3 | Non-Small Cell Lung Cancer | - | - |
Fidaxomicin | Phase 2 | Clostridium Difficile Infection | - | - |
SMT19969 | Phase 2 | Clostridium Difficile Infection | - | - |
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Summit Therapeutics Inc.'s drug pipeline?→
CatalystAlert tracks 7 drug candidates in Summit Therapeutics Inc.'s (SMMT) pipeline across Phase 3, Phase 2. Its lead program is AK112 Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Summit Therapeutics Inc.'s next FDA catalyst?→
Summit Therapeutics Inc.'s (SMMT) next tracked catalyst is a Acquisition expected October 2, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track SMMT biotech catalysts?→
Add SMMT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Summit Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.